TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Cancer Genomic Testing Market Insights, Forecast to 2028

Global Cancer Genomic Testing Market Insights, Forecast to 2028

  • Category:Life Sciences
  • Published on : 27 August 2022
  • Pages :107
  • Formats:
  • Report Code:SMR-7300703
OfferClick for best price

Best Price: $3920

Cancer Genomic Testing Market Size, Share 2022


Market Analysis and Insights: Global Cancer Genomic Testing Market

The global Cancer Genomic Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cancer Genomic Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cancer Genomic Testing market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cancer Genomic Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cancer Genomic Testing market.

Global Cancer Genomic Testing Scope and Market Size

Cancer Genomic Testing market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Cancer Genomic Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Breast Cancer Genomic Testing

Lung Cancer Genomic Testing

Blood Cancer Genomic Testing

Liver Cancer Genomic Testing

Stomach Cancer Genomic Testing

Others

Segment by Application

Hospitals

Clinics

Diagnostic Laboratories

Academic and Research Institutes

Others

By Company

Myriad Genetics

Centogene AG

Color Genomics

Quest Diagnostics

23andMe Inc.

Gene By Gene Ltd.

LabCorp

Positive Bioscience

Bio-Rad Laboratories

Illumina, Inc.

Agilent Technologies

Thermo Fisher Scientific

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Cancer Genomic Testing product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Cancer Genomic Testing, with price, sales, revenue, and global market share of Cancer Genomic Testing from 2019 to 2022.

Chapter 3, the Cancer Genomic Testing competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Cancer Genomic Testing breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Cancer Genomic Testing market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Cancer Genomic Testing.

Chapter 13, 14, and 15, to describe Cancer Genomic Testing sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Cancer Genomic Testing Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global Cancer Genomic Testing Market Insights, Forecast to 2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 107 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Genomic Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Breast Cancer Genomic Testing
1.2.3 Lung Cancer Genomic Testing
1.2.4 Blood Cancer Genomic Testing
1.2.5 Liver Cancer Genomic Testing
1.2.6 Stomach Cancer Genomic Testing
1.2.7 Others
1.3 Market by Application
1.3.1 Global Cancer Genomic Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostic Laboratories
1.3.5 Academic and Research Institutes
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cancer Genomic Testing Market Perspective (2017-2028)
2.2 Cancer Genomic Testing Growth Trends by Region
2.2.1 Cancer Genomic Testing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cancer Genomic Testing Historic Market Size by Region (2017-2022)
2.2.3 Cancer Genomic Testing Forecasted Market Size by Region (2023-2028)
2.3 Cancer Genomic Testing Market Dynamics
2.3.1 Cancer Genomic Testing Industry Trends
2.3.2 Cancer Genomic Testing Market Drivers
2.3.3 Cancer Genomic Testing Market Challenges
2.3.4 Cancer Genomic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Genomic Testing Players by Revenue
3.1.1 Global Top Cancer Genomic Testing Players by Revenue (2017-2022)
3.1.2 Global Cancer Genomic Testing Revenue Market Share by Players (2017-2022)
3.2 Global Cancer Genomic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Genomic Testing Revenue
3.4 Global Cancer Genomic Testing Market Concentration Ratio
3.4.1 Global Cancer Genomic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Genomic Testing Revenue in 2021
3.5 Cancer Genomic Testing Key Players Head office and Area Served
3.6 Key Players Cancer Genomic Testing Product Solution and Service
3.7 Date of Enter into Cancer Genomic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Genomic Testing Breakdown Data by Type
4.1 Global Cancer Genomic Testing Historic Market Size by Type (2017-2022)
4.2 Global Cancer Genomic Testing Forecasted Market Size by Type (2023-2028)
5 Cancer Genomic Testing Breakdown Data by Application
5.1 Global Cancer Genomic Testing Historic Market Size by Application (2017-2022)
5.2 Global Cancer Genomic Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cancer Genomic Testing Market Size (2017-2028)
6.2 North America Cancer Genomic Testing Market Size by Type
6.2.1 North America Cancer Genomic Testing Market Size by Type (2017-2022)
6.2.2 North America Cancer Genomic Testing Market Size by Type (2023-2028)
6.2.3 North America Cancer Genomic Testing Market Share by Type (2017-2028)
6.3 North America Cancer Genomic Testing Market Size by Application
6.3.1 North America Cancer Genomic Testing Market Size by Application (2017-2022)
6.3.2 North America Cancer Genomic Testing Market Size by Application (2023-2028)
6.3.3 North America Cancer Genomic Testing Market Share by Application (2017-2028)
6.4 North America Cancer Genomic Testing Market Size by Country
6.4.1 North America Cancer Genomic Testing Market Size by Country (2017-2022)
6.4.2 North America Cancer Genomic Testing Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Cancer Genomic Testing Market Size (2017-2028)
7.2 Europe Cancer Genomic Testing Market Size by Type
7.2.1 Europe Cancer Genomic Testing Market Size by Type (2017-2022)
7.2.2 Europe Cancer Genomic Testing Market Size by Type (2023-2028)
7.2.3 Europe Cancer Genomic Testing Market Share by Type (2017-2028)
7.3 Europe Cancer Genomic Testing Market Size by Application
7.3.1 Europe Cancer Genomic Testing Market Size by Application (2017-2022)
7.3.2 Europe Cancer Genomic Testing Market Size by Application (2023-2028)
7.3.3 Europe Cancer Genomic Testing Market Share by Application (2017-2028)
7.4 Europe Cancer Genomic Testing Market Size by Country
7.4.1 Europe Cancer Genomic Testing Market Size by Country (2017-2022)
7.4.2 Europe Cancer Genomic Testing Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Genomic Testing Market Size (2017-2028)
8.2 Asia-Pacific Cancer Genomic Testing Market Size by Type
8.2.1 Asia-Pacific Cancer Genomic Testing Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Cancer Genomic Testing Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Cancer Genomic Testing Market Share by Type (2017-2028)
8.3 Asia-Pacific Cancer Genomic Testing Market Size by Application
8.3.1 Asia-Pacific Cancer Genomic Testing Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Cancer Genomic Testing Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Cancer Genomic Testing Market Share by Application (2017-2028)
8.4 Asia-Pacific Cancer Genomic Testing Market Size by Region
8.4.1 Asia-Pacific Cancer Genomic Testing Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Cancer Genomic Testing Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cancer Genomic Testing Market Size (2017-2028)
9.2 Latin America Cancer Genomic Testing Market Size by Type
9.2.1 Latin America Cancer Genomic Testing Market Size by Type (2017-2022)
9.2.2 Latin America Cancer Genomic Testing Market Size by Type (2023-2028)
9.2.3 Latin America Cancer Genomic Testing Market Share by Type (2017-2028)
9.3 Latin America Cancer Genomic Testing Market Size by Application
9.3.1 Latin America Cancer Genomic Testing Market Size by Application (2017-2022)
9.3.2 Latin America Cancer Genomic Testing Market Size by Application (2023-2028)
9.3.3 Latin America Cancer Genomic Testing Market Share by Application (2017-2028)
9.4 Latin America Cancer Genomic Testing Market Size by Country
9.4.1 Latin America Cancer Genomic Testing Market Size by Country (2017-2022)
9.4.2 Latin America Cancer Genomic Testing Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Genomic Testing Market Size (2017-2028)
10.2 Middle East & Africa Cancer Genomic Testing Market Size by Type
10.2.1 Middle East & Africa Cancer Genomic Testing Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Cancer Genomic Testing Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Cancer Genomic Testing Market Share by Type (2017-2028)
10.3 Middle East & Africa Cancer Genomic Testing Market Size by Application
10.3.1 Middle East & Africa Cancer Genomic Testing Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Cancer Genomic Testing Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Cancer Genomic Testing Market Share by Application (2017-2028)
10.4 Middle East & Africa Cancer Genomic Testing Market Size by Country
10.4.1 Middle East & Africa Cancer Genomic Testing Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Cancer Genomic Testing Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Myriad Genetics
11.1.1 Myriad Genetics Company Details
11.1.2 Myriad Genetics Business Overview
11.1.3 Myriad Genetics Cancer Genomic Testing Introduction
11.1.4 Myriad Genetics Revenue in Cancer Genomic Testing Business (2017-2022)
11.1.5 Myriad Genetics Recent Developments
11.2 Centogene AG
11.2.1 Centogene AG Company Details
11.2.2 Centogene AG Business Overview
11.2.3 Centogene AG Cancer Genomic Testing Introduction
11.2.4 Centogene AG Revenue in Cancer Genomic Testing Business (2017-2022)
11.2.5 Centogene AG Recent Developments
11.3 Color Genomics
11.3.1 Color Genomics Company Details
11.3.2 Color Genomics Business Overview
11.3.3 Color Genomics Cancer Genomic Testing Introduction
11.3.4 Color Genomics Revenue in Cancer Genomic Testing Business (2017-2022)
11.3.5 Color Genomics Recent Developments
11.4 Quest Diagnostics
11.4.1 Quest Diagnostics Company Details
11.4.2 Quest Diagnostics Business Overview
11.4.3 Quest Diagnostics Cancer Genomic Testing Introduction
11.4.4 Quest Diagnostics Revenue in Cancer Genomic Testing Business (2017-2022)
11.4.5 Quest Diagnostics Recent Developments
11.5 23andMe Inc.
11.5.1 23andMe Inc. Company Details
11.5.2 23andMe Inc. Business Overview
11.5.3 23andMe Inc. Cancer Genomic Testing Introduction
11.5.4 23andMe Inc. Revenue in Cancer Genomic Testing Business (2017-2022)
11.5.5 23andMe Inc. Recent Developments
11.6 Gene By Gene Ltd.
11.6.1 Gene By Gene Ltd. Company Details
11.6.2 Gene By Gene Ltd. Business Overview
11.6.3 Gene By Gene Ltd. Cancer Genomic Testing Introduction
11.6.4 Gene By Gene Ltd. Revenue in Cancer Genomic Testing Business (2017-2022)
11.6.5 Gene By Gene Ltd. Recent Developments
11.7 LabCorp
11.7.1 LabCorp Company Details
11.7.2 LabCorp Business Overview
11.7.3 LabCorp Cancer Genomic Testing Introduction
11.7.4 LabCorp Revenue in Cancer Genomic Testing Business (2017-2022)
11.7.5 LabCorp Recent Developments
11.8 Positive Bioscience
11.8.1 Positive Bioscience Company Details
11.8.2 Positive Bioscience Business Overview
11.8.3 Positive Bioscience Cancer Genomic Testing Introduction
11.8.4 Positive Bioscience Revenue in Cancer Genomic Testing Business (2017-2022)
11.8.5 Positive Bioscience Recent Developments
11.9 Bio-Rad Laboratories
11.9.1 Bio-Rad Laboratories Company Details
11.9.2 Bio-Rad Laboratories Business Overview
11.9.3 Bio-Rad Laboratories Cancer Genomic Testing Introduction
11.9.4 Bio-Rad Laboratories Revenue in Cancer Genomic Testing Business (2017-2022)
11.9.5 Bio-Rad Laboratories Recent Developments
11.10 Illumina, Inc.
11.10.1 Illumina, Inc. Company Details
11.10.2 Illumina, Inc. Business Overview
11.10.3 Illumina, Inc. Cancer Genomic Testing Introduction
11.10.4 Illumina, Inc. Revenue in Cancer Genomic Testing Business (2017-2022)
11.10.5 Illumina, Inc. Recent Developments
11.11 Agilent Technologies
11.11.1 Agilent Technologies Company Details
11.11.2 Agilent Technologies Business Overview
11.11.3 Agilent Technologies Cancer Genomic Testing Introduction
11.11.4 Agilent Technologies Revenue in Cancer Genomic Testing Business (2017-2022)
11.11.5 Agilent Technologies Recent Developments
11.12 Thermo Fisher Scientific
11.12.1 Thermo Fisher Scientific Company Details
11.12.2 Thermo Fisher Scientific Business Overview
11.12.3 Thermo Fisher Scientific Cancer Genomic Testing Introduction
11.12.4 Thermo Fisher Scientific Revenue in Cancer Genomic Testing Business (2017-2022)
11.12.5 Thermo Fisher Scientific Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Cancer Genomic Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Breast Cancer Genomic Testing
Table 3. Key Players of Lung Cancer Genomic Testing
Table 4. Key Players of Blood Cancer Genomic Testing
Table 5. Key Players of Liver Cancer Genomic Testing
Table 6. Key Players of Stomach Cancer Genomic Testing
Table 7. Key Players of Others
Table 8. Global Cancer Genomic Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 9. Global Cancer Genomic Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 10. Global Cancer Genomic Testing Market Size by Region (2017-2022) & (US$ Million)
Table 11. Global Cancer Genomic Testing Market Share by Region (2017-2022)
Table 12. Global Cancer Genomic Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 13. Global Cancer Genomic Testing Market Share by Region (2023-2028)
Table 14. Cancer Genomic Testing Market Trends
Table 15. Cancer Genomic Testing Market Drivers
Table 16. Cancer Genomic Testing Market Challenges
Table 17. Cancer Genomic Testing Market Restraints
Table 18. Global Cancer Genomic Testing Revenue by Players (2017-2022) & (US$ Million)
Table 19. Global Cancer Genomic Testing Revenue Share by Players (2017-2022)
Table 20. Global Top Cancer Genomic Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Genomic Testing as of 2021)
Table 21. Ranking of Global Top Cancer Genomic Testing Companies by Revenue (US$ Million) in 2021
Table 22. Global 5 Largest Players Market Share by Cancer Genomic Testing Revenue (CR5 and HHI) & (2017-2022)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Cancer Genomic Testing Product Solution and Service
Table 25. Date of Enter into Cancer Genomic Testing Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Cancer Genomic Testing Market Size by Type (2017-2022) & (US$ Million)
Table 28. Global Cancer Genomic Testing Revenue Market Share by Type (2017-2022)
Table 29. Global Cancer Genomic Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 30. Global Cancer Genomic Testing Revenue Market Share by Type (2023-2028)
Table 31. Global Cancer Genomic Testing Market Size by Application (2017-2022) & (US$ Million)
Table 32. Global Cancer Genomic Testing Revenue Share by Application (2017-2022)
Table 33. Global Cancer Genomic Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 34. Global Cancer Genomic Testing Revenue Share by Application (2023-2028)
Table 35. North America Cancer Genomic Testing Market Size by Type (2017-2022) & (US$ Million)
Table 36. North America Cancer Genomic Testing Market Size by Type (2023-2028) & (US$ Million)
Table 37. North America Cancer Genomic Testing Market Size by Application (2017-2022) & (US$ Million)
Table 38. North America Cancer Genomic Testing Market Size by Application (2023-2028) & (US$ Million)
Table 39. North America Cancer Genomic Testing Market Size by Country (2017-2022) & (US$ Million)
Table 40. North America Cancer Genomic Testing Market Size by Country (2023-2028) & (US$ Million)
Table 41. Europe Cancer Genomic Testing Market Size by Type (2017-2022) & (US$ Million)
Table 42. Europe Cancer Genomic Testing Market Size by Type (2023-2028) & (US$ Million)
Table 43. Europe Cancer Genomic Testing Market Size by Application (2017-2022) & (US$ Million)
Table 44. Europe Cancer Genomic Testing Market Size by Application (2023-2028) & (US$ Million)
Table 45. Europe Cancer Genomic Testing Market Size by Country (2017-2022) & (US$ Million)
Table 46. Europe Cancer Genomic Testing Market Size by Country (2023-2028) & (US$ Million)
Table 47. Asia Pacific Cancer Genomic Testing Market Size by Type (2017-2022) & (US$ Million)
Table 48. Asia Pacific Cancer Genomic Testing Market Size by Type (2023-2028) & (US$ Million)
Table 49. Asia Pacific Cancer Genomic Testing Market Size by Application (2017-2022) & (US$ Million)
Table 50. Asia Pacific Cancer Genomic Testing Market Size by Application (2023-2028) & (US$ Million)
Table 51. Asia Pacific Cancer Genomic Testing Market Size by Region (2017-2022) & (US$ Million)
Table 52. Asia Pacific Cancer Genomic Testing Market Size by Region (2023-2028) & (US$ Million)
Table 53. Latin America Cancer Genomic Testing Market Size by Type (2017-2022) & (US$ Million)
Table 54. Latin America Cancer Genomic Testing Market Size by Type (2023-2028) & (US$ Million)
Table 55. Latin America Cancer Genomic Testing Market Size by Application (2017-2022) & (US$ Million)
Table 56. Latin America Cancer Genomic Testing Market Size by Application (2023-2028) & (US$ Million)
Table 57. Latin America Cancer Genomic Testing Market Size by Country (2017-2022) & (US$ Million)
Table 58. Latin America Cancer Genomic Testing Market Size by Country (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Cancer Genomic Testing Market Size by Type (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Cancer Genomic Testing Market Size by Type (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Cancer Genomic Testing Market Size by Application (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Cancer Genomic Testing Market Size by Application (2023-2028) & (US$ Million)
Table 63. Middle East and Africa Cancer Genomic Testing Market Size by Country (2017-2022) & (US$ Million)
Table 64. Middle East and Africa Cancer Genomic Testing Market Size by Country (2023-2028) & (US$ Million)
Table 65. Myriad Genetics Company Details
Table 66. Myriad Genetics Business Overview
Table 67. Myriad Genetics Cancer Genomic Testing Product
Table 68. Myriad Genetics Revenue in Cancer Genomic Testing Business (2017-2022) & (US$ Million)
Table 69. Myriad Genetics Recent Developments
Table 70. Centogene AG Company Details
Table 71. Centogene AG Business Overview
Table 72. Centogene AG Cancer Genomic Testing Product
Table 73. Centogene AG Revenue in Cancer Genomic Testing Business (2017-2022) & (US$ Million)
Table 74. Centogene AG Recent Developments
Table 75. Color Genomics Company Details
Table 76. Color Genomics Business Overview
Table 77. Color Genomics Cancer Genomic Testing Product
Table 78. Color Genomics Revenue in Cancer Genomic Testing Business (2017-2022) & (US$ Million)
Table 79. Color Genomics Recent Developments
Table 80. Quest Diagnostics Company Details
Table 81. Quest Diagnostics Business Overview
Table 82. Quest Diagnostics Cancer Genomic Testing Product
Table 83. Quest Diagnostics Revenue in Cancer Genomic Testing Business (2017-2022) & (US$ Million)
Table 84. Quest Diagnostics Recent Developments
Table 85. 23andMe Inc. Company Details
Table 86. 23andMe Inc. Business Overview
Table 87. 23andMe Inc. Cancer Genomic Testing Product
Table 88. 23andMe Inc. Revenue in Cancer Genomic Testing Business (2017-2022) & (US$ Million)
Table 89. 23andMe Inc. Recent Developments
Table 90. Gene By Gene Ltd. Company Details
Table 91. Gene By Gene Ltd. Business Overview
Table 92. Gene By Gene Ltd. Cancer Genomic Testing Product
Table 93. Gene By Gene Ltd. Revenue in Cancer Genomic Testing Business (2017-2022) & (US$ Million)
Table 94. Gene By Gene Ltd. Recent Developments
Table 95. LabCorp Company Details
Table 96. LabCorp Business Overview
Table 97. LabCorp Cancer Genomic Testing Product
Table 98. LabCorp Revenue in Cancer Genomic Testing Business (2017-2022) & (US$ Million)
Table 99. LabCorp Recent Developments
Table 100. Positive Bioscience Company Details
Table 101. Positive Bioscience Business Overview
Table 102. Positive Bioscience Cancer Genomic Testing Product
Table 103. Positive Bioscience Revenue in Cancer Genomic Testing Business (2017-2022) & (US$ Million)
Table 104. Positive Bioscience Recent Developments
Table 105. Bio-Rad Laboratories Company Details
Table 106. Bio-Rad Laboratories Business Overview
Table 107. Bio-Rad Laboratories Cancer Genomic Testing Product
Table 108. Bio-Rad Laboratories Revenue in Cancer Genomic Testing Business (2017-2022) & (US$ Million)
Table 109. Bio-Rad Laboratories Recent Developments
Table 110. Illumina, Inc. Company Details
Table 111. Illumina, Inc. Business Overview
Table 112. Illumina, Inc. Cancer Genomic Testing Product
Table 113. Illumina, Inc. Revenue in Cancer Genomic Testing Business (2017-2022) & (US$ Million)
Table 114. Illumina, Inc. Recent Developments
Table 115. Agilent Technologies Company Details
Table 116. Agilent Technologies Business Overview
Table 117. Agilent Technologies Cancer Genomic Testing Product
Table 118. Agilent Technologies Revenue in Cancer Genomic Testing Business (2017-2022) & (US$ Million)
Table 119. Agilent Technologies Recent Developments
Table 120. Thermo Fisher Scientific Company Details
Table 121. Thermo Fisher Scientific Business Overview
Table 122. Thermo Fisher Scientific Cancer Genomic Testing Product
Table 123. Thermo Fisher Scientific Revenue in Cancer Genomic Testing Business (2017-2022) & (US$ Million)
Table 124. Thermo Fisher Scientific Recent Developments
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Genomic Testing Market Share by Type: 2021 VS 2028
Figure 2. Breast Cancer Genomic Testing Features
Figure 3. Lung Cancer Genomic Testing Features
Figure 4. Blood Cancer Genomic Testing Features
Figure 5. Liver Cancer Genomic Testing Features
Figure 6. Stomach Cancer Genomic Testing Features
Figure 7. Others Features
Figure 8. Global Cancer Genomic Testing Market Share by Application: 2021 VS 2028
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Diagnostic Laboratories Case Studies
Figure 12. Academic and Research Institutes Case Studies
Figure 13. Others Case Studies
Figure 14. Cancer Genomic Testing Report Years Considered
Figure 15. Global Cancer Genomic Testing Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 16. Global Cancer Genomic Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global Cancer Genomic Testing Market Share by Region: 2021 VS 2028
Figure 18. Global Cancer Genomic Testing Market Share by Players in 2021
Figure 19. Global Top Cancer Genomic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Genomic Testing as of 2021)
Figure 20. The Top 10 and 5 Players Market Share by Cancer Genomic Testing Revenue in 2021
Figure 21. North America Cancer Genomic Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 22. North America Cancer Genomic Testing Market Size Market Share by Type (2017-2028)
Figure 23. North America Cancer Genomic Testing Market Size Market Share by Application (2017-2028)
Figure 24. North America Cancer Genomic Testing Market Size Share by Country (2017-2028)
Figure 25. United States Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Canada Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Europe Cancer Genomic Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 28. Europe Cancer Genomic Testing Market Size Market Share by Type (2017-2028)
Figure 29. Europe Cancer Genomic Testing Market Size Market Share by Application (2017-2028)
Figure 30. Europe Cancer Genomic Testing Market Size Share by Country (2017-2028)
Figure 31. Germany Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. France Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. U.K. Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Italy Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Russia Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Nordic Countries Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Asia-Pacific Cancer Genomic Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 38. Asia Pacific Cancer Genomic Testing Market Size Market Share by Type (2017-2028)
Figure 39. Asia Pacific Cancer Genomic Testing Market Size Market Share by Application (2017-2028)
Figure 40. Asia Pacific Cancer Genomic Testing Market Size Share by Region (2017-2028)
Figure 41. China Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Japan Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. South Korea Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Southeast Asia Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. India Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Australia Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 47. Latin America Cancer Genomic Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Latin America Cancer Genomic Testing Market Size Market Share by Type (2017-2028)
Figure 49. Latin America Cancer Genomic Testing Market Size Market Share by Application (2017-2028)
Figure 50. Latin America Cancer Genomic Testing Market Size Share by Country (2017-2028)
Figure 51. Mexico Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Brazil Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Middle East & Africa Cancer Genomic Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 54. Middle East and Africa Cancer Genomic Testing Market Size Market Share by Type (2017-2028)
Figure 55. Middle East and Africa Cancer Genomic Testing Market Size Market Share by Application (2017-2028)
Figure 56. Middle East and Africa Cancer Genomic Testing Market Size Share by Country (2017-2028)
Figure 57. Turkey Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. Saudi Arabia Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 59. UAE Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 60. Myriad Genetics Revenue Growth Rate in Cancer Genomic Testing Business (2017-2022)
Figure 61. Centogene AG Revenue Growth Rate in Cancer Genomic Testing Business (2017-2022)
Figure 62. Color Genomics Revenue Growth Rate in Cancer Genomic Testing Business (2017-2022)
Figure 63. Quest Diagnostics Revenue Growth Rate in Cancer Genomic Testing Business (2017-2022)
Figure 64. 23andMe Inc. Revenue Growth Rate in Cancer Genomic Testing Business (2017-2022)
Figure 65. Gene By Gene Ltd. Revenue Growth Rate in Cancer Genomic Testing Business (2017-2022)
Figure 66. LabCorp Revenue Growth Rate in Cancer Genomic Testing Business (2017-2022)
Figure 67. Positive Bioscience Revenue Growth Rate in Cancer Genomic Testing Business (2017-2022)
Figure 68. Bio-Rad Laboratories Revenue Growth Rate in Cancer Genomic Testing Business (2017-2022)
Figure 69. Illumina, Inc. Revenue Growth Rate in Cancer Genomic Testing Business (2017-2022)
Figure 70. Agilent Technologies Revenue Growth Rate in Cancer Genomic Testing Business (2017-2022)
Figure 71. Thermo Fisher Scientific Revenue Growth Rate in Cancer Genomic Testing Business (2017-2022)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount